Abstract:
본 발명은 코지산(kojic acid) 유도체 화합물을 유효성분으로 함유하는 항암용 조성물에 관한 것이다. 본 발명에 따른 코지산 유도체 화합물은 Src계 키나아제 활성을 억제함으로써 신경교종(glioma) 세포의 증식을 저해하고, 대식세포에서의 TLR4 매개 활성을 억제하는 효과가 우수하여 신경교종 유래의 종양에 대한 치료 및 예방에 유용하게 사용될 수 있다. 코지산 유도체, 신경교종, Src 키나아제, 대식세포, 세포증식, 종양
Abstract:
PURPOSE: A composition containing Hopea odorata Roxb. extract with anti-inflammation is provided to control macrophage function and to prevent and treat acure/chronic inflammation immunity and autoimmune response. CONSTITUTION: A pharmaceutical composition contains Hopea odorata Roxb. extract as an active ingredient. The extract is isolated using methanol, ethanol, or water. The extract is prepared by isolating Hopea odorata Roxb. with ethanol, suspending with water, and fractioning with n-hexane, ethyl acetate, and n-butanol. The extract is prepared in the form of a carrier, excipient, or diluent. The extract suppresses NO generation and pro-inflammatory cytokines(IL-6, GM-CSF, IL-1β and TNF-alpha). A neutraceutical food contains the hot water extract of Hopea odorata Roxb. as an active ingredient.
Abstract:
본 발명은 더덕 추출물 또는 더덕 사포닌을 유효성분으로 포함하는 비만세포로부터 히스타민의 분비를 억제하는 효과를 갖는 조성물에 관한 것이다. 본 발명의 조성물과 이를 포함하는 제품은 소양증을 비롯하여 발적, 화끈거리는 열감, 두드러기, 재채기, 맑은 콧물, 코막힘, 객담증가, 흉부압박감, 호흡곤란, 순환기계의 빈맥, 저혈압, 전신 무기력증, 어지러움증과 같은 히스타민의 필요이상의 분비로 인하여 발생되는 질병이나 증상의 예방 또는 치료용도로 사용될 수 있다. 본 발명의 조성물 및 이를 함유하는 제품은 사람뿐만 아니라 동물에도 적용할 수 있다. 더덕, 사포닌, 소양증, 비만세포, 탈과립, 히스타민
Abstract:
PURPOSE: A Dryopteris Crassirhizoma extract with activity of anti-inflammation and immunity regulation is provided to suppress expression and generation of TNF-alpha and prostaglandin. CONSTITUTION: A composition for anti-inflammation and immunity regulation contains Dryopteris Crassirhizoma extract as an active ingredient. The Dryopteris Crassirhizoma extract suppresses NO generation. The composition contains 12.5 ug/ml or more of Dryopteris Crassirhizoma extract as an active ingredient.
Abstract:
본 발명은 케나프 추출물과 이로부터 분리된 신규 캠프페롤 화합물 및 이의 식품으로서의 용도에 관한 것으로서, 더욱 상세하게는 케나프( Hibiscus
cannabbinus L., Malvaceae) 추출물과 이로부터 분리된 신규 캠프페롤 화합물이 항균 및 항산화 활성을 나타냄을 밝히고, 이를 식품으로 적용하기 위한 새로운 용도에 관한 것이다. 케나프(Hibiscus cannabbinus L., Malvaceae), 캠프페롤 화합물
Abstract:
An extract of Hibiscus cannabinus L.(Malvaceae) and a novel kaempferol compound isolated therefrom are provided to inhibit growth of microorganisms, oxidation and aging in the skin without side effects, so that they are useful in medicines, cosmetics and functional food for improving skin beauty. An extract of Hibiscus cannabinus L. having improved antimicrobial and antioxidizing effects is prepared by extracting Hibiscus cannabinus L. with a solvent selected from water, aliphatic alcohol or alcohol solution, hexane, chloroform and ethylacetate. A novel kaempferol compound represented by the formula(1) is isolated from the extract of Hibiscus cannabinus L. by extracting Hibiscus cannabinus L. with methanol, extracting the crude methanol extract with water, aliphatic alcohol, alcohol solution, hexane, chloroform or ethylacetate to obtain a water layer and an organic layer, and subjecting the water layer and organic layer to silica chromatography, gel filtration chromatography and HPLC(high performance liquid chromatography), sequentially.
Abstract:
The present invention relates to an anti-inflammatory active composition containing a Beauveria sungii butanol fraction (BSBF) as an active ingredient. The BSBF according to the present invention inhibits the activation of NFkB by controlling the generation of NO caused by iNOS and COX-2 which are known as important factors of inflammatory reaction and by controlling the phoshorylation of IkB so that COX-2 expression is controlled. The BSBF also controls ROS generation so that the expressions of NFKB and p38 are controlled and inflammation can be effectively controlled.
Abstract:
본 발명은 5-[4'-(피페리디노메틸)페닐]-2,3-디히드로이미다조[2,1-a]이소퀴놀린의 신규한 의약용도에 관한 것으로서, 더욱 상세하게는 염증반응인자로서의 종양괴사인자 (TNF)-알파의 생성 억제, 종양괴사인자 (TNF)-알파, 인터류킨(IL)-1 베타 및 인터류킨-6의 mRNA 발현 억제, 식세포 작용 능력 억제 및 산화질소(nitric oxide, NO) 생성 억제의 효과를 기초 한 염증성 질병 또는 면역질환의 예방 또는 치료용도에 관한 것이다. 5-[4'-(피페리디노메틸)페닐]-2,3-디히드로이미다조[2,1-a]이소퀴놀린, 항염증활성, 대식세포, 사이토카인
Abstract:
The present invention relates to (2R,3R,4R,5R)-1,6-bis(4-(2,4,4-trimethylpentan-2-yl)phenoxy)hexane-2,3,4,5-tetraol which is a novel anti-cancer functional substance unknown until now and which is manufactured by being designed by using militarin of Cordyceps militaris, and identifies anti-cancer mechanism of the compound by using various assays. The compound has an excellent effect of providing a biopharmaceutical material as an anti-cancer drug.